Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Arthritis, Rheumatoid 5Colitis, Ulcerative 2Recurrence 1Lymphoma 1Inflammatory Bowel Diseases 1Crohn Disease 1

Interventions

etrolizumab 5Infliximab 4Adalimumab 3golimumab 2CT-P13 2peficitinib 1Sutures 1Surgical Instruments 1Ringer's Lactate 1Proctectomy 1Pneumococcal Vaccines 1Papillomavirus Vaccines 1Methylprednisolone 1Mesalamine 1Lysine Acetyltransferase 5 1Laparoscopy 1Injections 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Eicosapentaenoic Acid 1CVD protocol 1ABX464 12-(3',4'-dihydroxyphenyl-1-azo)benzimidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Colitis, Ulcerative × golimumab × Clear all
NCT03011268 2025-05-31

BIOSTOP

Helse Møre og Romsdal HF

Phase NA Completed
174 enrolled

Colitis, Ulcerative, Recurrence

NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡